Atropos Health furthers commitment to Oncology with addition of Ontada data

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Analytics
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
  • Technology
        • Platform
          • GENEVA OS™
        • Evidence Generation Tools
          • ChatRWD®
          • Green Button™
          • Alexandria™
          • Forge™
        • Data
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Release
  • Contact Us
  • Login
Impact of Adherence to Guideline-Directed Medical Therapy of Clinical Outcomes in Older Patients w/ Heart Failure with Reduced Ejection Fraction

Impact of Adherence to Guideline-Directed Medical Therapy of Clinical Outcomes in Older Patients w/ Heart Failure with Reduced Ejection Fraction

by webbed@meshagency.com | Sep 12, 2024 | Publications

Xichong Liu, MD, Chan Hee J. Choi, MD, PhD, Vinita Shastri, MD, Shriram Nallamshetty, MD
Association of Systemic Diseases With Surgical Treatment for Obstructive Sleep Apnea Compared With Continuous Positive Airway Pressure.

Association of Systemic Diseases With Surgical Treatment for Obstructive Sleep Apnea Compared With Continuous Positive Airway Pressure.

by Maria Hernandez | Sep 4, 2024 | Publications

Badr Ibrahim et. to the. JAMA Otolaryngol Head Neck Surg. Published online January 2021
GLP-1 RA and Risk of Malignancy in Patients with Type 2 Diabetes

GLP-1 RA and Risk of Malignancy in Patients with Type 2 Diabetes

by Julia Rudo | Jun 14, 2024 | Publications

An abstract titled, “GLP-1 RA and Risk of Malignancy in Patients with Type 2 Diabetes,” was published in Diabetes, a publication from the American Diabetes Association, and subsequently presented by authors Faidat A. Ishola, C. William Pike, and Sun H. Kim. Dr. Pike...
GLP-1 Agonists Can Prevent Liver Disease Progression in Patients with Metabolic and Alcohol-Associated Liver Disease (METALD)

GLP-1 Agonists Can Prevent Liver Disease Progression in Patients with Metabolic and Alcohol-Associated Liver Disease (METALD)

by Julia Rudo | May 20, 2024 | Publications

An abstract titled, “GLP-1 Agonists Can Prevent Liver Disease Progression in Patients with Metabolic and Alcohol-Associated Liver Disease (MetALD),” was published in Digestive Disease Week and subsequently presented by authors Amir Gougol, C. William Pike, Niloufar...
Journal of Clinical Neuroscience Publishes “Antipsychotic medications associated with increased length of hospital stay”

Journal of Clinical Neuroscience Publishes “Antipsychotic medications associated with increased length of hospital stay”

by Maria Hernandez | Apr 30, 2024 | Publications

On April 26, 2024, the Journal of Clinical Neuroscience published “Antipsychotic medications associated with increased length of hospital stay in autoimmune encephalitis and multiple sclerosis: A retrospective study” by Stephen Sai Folmsbee a, Gavin Hui b, Ye Yuan b,...
« Older Entries
Next Entries »
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Analytics

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Technology

Platform

GENEVA OS™

Evidence Generation Tools

ChatRWD®

Green Button™

Alexandria™

Forge™

Data

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Release

Copyright © 2024 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}